Search Within

Francois Jean Marie Audenet

  1. "2019"
Formats
  1. Journal Article (3)
  2. Editorial (1)
Groups
  1. Department of Medicine (4)
  2. Department of Pathology and Laboratory Medicine (4)
  3. GSK Faculty (4)
  4. Genitourinary Oncology Service (4)
  5. Human Oncology and Pathogenesis Program (4)
  6. Solid Tumor Oncology Division (4)

More Groups

People
  1. Bernard Bochner (4)
  2. David Solit (4)
  3. Eugene Pietzak (4)
  4. Gopakumar Iyer (4)
  5. Hikmat Al-Ahmadie (4)
  6. Maria Arcila (4)

More People

Years
  1. 2019 (4)
Publications
  1. European Urology Focus (2)
  2. Clinical Cancer Research (1)
  3. European Urology (1)
Publishers
  1. Elsevier B.V. (2)
  2. American Association for Cancer Research (1)
  3. Elsevier Science, Inc. (1)

Results (4)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Genomic profile of urothelial carcinoma of the upper tract from ureteroscopic biopsy: Feasibility and validation using matched radical nephroureterectomy specimens
    Journal Article

    Bagrodia, A.; Audenet, F.; Pietzak, E. J.; Kim, K.; Murray, K. S.; Cha, E. K.; Sfakianos, J. P.; Iyer, G.; Singla, N.; Arcila, M.; more...
    European Urology Focus (2019)

    Fulltext@MSK | Save
  • Prognostic value of TERT alterations, mutational and copy number alterations burden in urothelial carcinoma
    Journal Article

    Isharwal, S.; Audenet, F.; Drill, E.; Pietzak, E. J.; Iyer, G.; Ostrovnaya, I.; Cha, E.; Donahue, T.; Arcila, M.; Jayakumaran, G.; more...
    European Urology Focus (2019)

    Fulltext@MSK | Save
  • Clonal relatedness and mutational differences between upper tract and bladder urothelial carcinoma
    Journal Article

    Audenet, F.; Isharwal, S.; Cha, E. K.; Donoghue, M. T. A.; Drill, E. N.; Ostrovnaya, I.; Pietzak, E. J.; Sfakianos, J. P.; Bagrodia, A.; Murugan, P.; more...
    Clinical Cancer Research (2019)

    Fulltext@MSK | Save
  • Genomic differences between “primary” and “secondary” muscle-invasive bladder cancer as a basis for disparate outcomes to cisplatin-based neoadjuvant chemotherapy
    Editorial

    Pietzak, E. J.; Zabor, E. C.; Bagrodia, A.; Armenia, J.; Hu, W.; Zehir, A.; Funt, S.; Audenet, F.; Barron, D.; Maamouri, N.; more...
    European Urology (2019)

    Fulltext@MSK | Save